Montpellier, France

Valérie Courgnaud

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.4

ph-index = 1


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Valérie Courgnaud: Innovator in Medical Diagnostics

Introduction

Valérie Courgnaud is a prominent inventor based in Montpellier, France. He has made significant contributions to the field of medical diagnostics, particularly in relation to diseases associated with sodium-dependent multivitamin transporters and cationic l-amino acid transporters. With a total of 3 patents, Courgnaud's work is paving the way for advancements in diagnostic methods.

Latest Patents

Courgnaud's latest patents include innovative methods for diagnosing and measuring levels of sodium-dependent multivitamin transporter (SMVT) in biological samples. One patent focuses on the use of ligands derived from the receptor-binding domain of porcine endogenous retrovirus type B for diagnosing SMVT-related diseases. The method involves contacting a biological sample with a PERV-B.RBD ligand and detecting the binding to SMVT. Another patent addresses the diagnosis and treatment of cationic l-amino acid transporter-related diseases using a receptor-binding domain derived from bovine leukemia virus. This method includes detecting CAT1 in a cell by a BLV.RBD ligand.

Career Highlights

Throughout his career, Courgnaud has worked with notable organizations such as Metafora Biosystems and the Centre National De La Recherche Scientifique. His experience in these institutions has allowed him to develop and refine his innovative diagnostic methods.

Collaborations

Courgnaud has collaborated with esteemed colleagues, including Marc Sitbon and Vincent Petit. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Valérie Courgnaud is a distinguished inventor whose work in medical diagnostics is making a significant impact. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…